143 related articles for article (PubMed ID: 24883440)
1. Riociguat recommended by CHMP for approval in the EU for use in two forms of pulmonary hypertension.
Dowdall M
Future Cardiol; 2014 Mar; 10(2):163. PubMed ID: 24883440
[No Abstract] [Full Text] [Related]
2. Recruitment of pulmonary hypertension patients for PATENT trial with Riociguat [corrected] completed Sub-Saharan pulmonary hypertension study launched.
Aalbers J
Cardiovasc J Afr; 2012 Mar; 23(2):120. PubMed ID: 22447482
[No Abstract] [Full Text] [Related]
3. Riociguat for pulmonary hypertension.
Ghofrani HA; Voswinckel R; Gall H; Schermuly R; Weissmann N; Seeger W; Grimminger F
Future Cardiol; 2010 Mar; 6(2):155-66. PubMed ID: 20230258
[TBL] [Abstract][Full Text] [Related]
4. Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. Food and Drug Administration.
Hill NS; Badesch D; Benza RL; D'Eletto TA; Farber HW; Gomberg-Maitland M; Hassoun PM; Preston I
Ann Am Thorac Soc; 2015 Feb; 12(2):269-73. PubMed ID: 25590376
[TBL] [Abstract][Full Text] [Related]
5. Riociguat for the treatment of pulmonary hypertension.
Hambly N; Granton J
Expert Rev Respir Med; 2015; 9(6):679-95. PubMed ID: 26599488
[TBL] [Abstract][Full Text] [Related]
6. [Targeted therapy of pulmonary arterial hypertension (PAH)].
Klose H; Opitz C; Bremer H; Ewert R; Bonderman D; Rosenkranz S; Seeger W; Schmeißer A; Harbaum L; Buerke M; Ghofrani HA; Borst MM; Leuchte HH; Lange TJ; Behr J; Ulrich S; Lang I; Olschewski H; Gall H; Kabitz HJ; Kleber FX; Held M; Hoeper MM; Grünig E
Dtsch Med Wochenschr; 2014 Dec; 139 Suppl 4():S142-50. PubMed ID: 25489684
[No Abstract] [Full Text] [Related]
7. Riociguat, an oral soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension.
Belik J
Curr Opin Investig Drugs; 2009 Sep; 10(9):971-9. PubMed ID: 19705340
[TBL] [Abstract][Full Text] [Related]
8. [Pulmonary hypertension].
Kovacs G; Olschewski H
Dtsch Med Wochenschr; 2012 Oct; 137(40):2026-8. PubMed ID: 23023615
[No Abstract] [Full Text] [Related]
9. Changing perceptions in pulmonary hypertension.
Gerges C; Lang IM
Lancet Respir Med; 2014 Jan; 2(1):21-3. PubMed ID: 24461891
[No Abstract] [Full Text] [Related]
10. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension.
Ghofrani HA; D'Armini AM; Grimminger F; Hoeper MM; Jansa P; Kim NH; Mayer E; Simonneau G; Wilkins MR; Fritsch A; Neuser D; Weimann G; Wang C;
N Engl J Med; 2013 Jul; 369(4):319-29. PubMed ID: 23883377
[TBL] [Abstract][Full Text] [Related]
11. Riociguat approved for pulmonary hypertension.
Traynor K
Am J Health Syst Pharm; 2013 Nov; 70(22):1960. PubMed ID: 24173000
[No Abstract] [Full Text] [Related]
12. New insights into pulmonary hypertension.
Furlow B
Lancet Respir Med; 2013 Sep; 1(7):508. PubMed ID: 24461605
[No Abstract] [Full Text] [Related]
13. Riociguat for the treatment of pulmonary arterial hypertension.
Ghofrani HA; Galiè N; Grimminger F; Grünig E; Humbert M; Jing ZC; Keogh AM; Langleben D; Kilama MO; Fritsch A; Neuser D; Rubin LJ;
N Engl J Med; 2013 Jul; 369(4):330-40. PubMed ID: 23883378
[TBL] [Abstract][Full Text] [Related]
14. Riociguat for the management of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Larche NE; Mousa SA
Drugs Today (Barc); 2013 Dec; 49(12):761-8. PubMed ID: 24524094
[TBL] [Abstract][Full Text] [Related]
15. Riociguat for pulmonary hypertension.
Cannon JE; Pepke-Zaba J
Expert Rev Clin Pharmacol; 2014 May; 7(3):259-70. PubMed ID: 24580082
[TBL] [Abstract][Full Text] [Related]
16. Riociguat (Adempas). Chronic thromboembolic pulmonary hypertension with markedly restricted physical activity.
Prescrire Int; 2015 Nov; 24(165):265-6. PubMed ID: 26688897
[TBL] [Abstract][Full Text] [Related]
17. Left ventricular systolic dysfunction associated with pulmonary hypertension riociguat trial (LEPHT): rationale and design.
Ghio S; Bonderman D; Felix SB; Ghofrani HA; Michelakis ED; Mitrovic V; Oudiz RJ; Frey R; Roessig L; Semigran MJ
Eur J Heart Fail; 2012 Aug; 14(8):946-53. PubMed ID: 22719060
[TBL] [Abstract][Full Text] [Related]
18. Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2).
Rubin LJ; Galiè N; Grimminger F; Grünig E; Humbert M; Jing ZC; Keogh A; Langleben D; Fritsch A; Menezes F; Davie N; Ghofrani HA
Eur Respir J; 2015 May; 45(5):1303-13. PubMed ID: 25614164
[TBL] [Abstract][Full Text] [Related]
19. [The SERAPHIN study].
D'Alto M; Vitulo P
G Ital Cardiol (Rome); 2015 Jan; 16(1):6-10. PubMed ID: 25689745
[No Abstract] [Full Text] [Related]
20. Riociguat for the treatment of pulmonary hypertension.
Schermuly RT; Janssen W; Weissmann N; Stasch JP; Grimminger F; Ghofrani HA
Expert Opin Investig Drugs; 2011 Apr; 20(4):567-76. PubMed ID: 21391889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
